Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2001, p. 800-804, Vol. 45, No. 3
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.3.800-804.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of P55, a Multidrug Efflux Pump in
Mycobacterium bovis and Mycobacterium
tuberculosis
Pedro E. A.
Silva,1
Fabiana
Bigi,2
María
de la
Paz Santangelo,2
Maria Isabel
Romano,2
Carlos
Martín,1
Angel
Cataldi,2 and
José A.
Aínsa1,*
Departamento de Microbiología,
Medicina Preventiva y Salud Pública, Facultad de Medicina,
Universidad de Zaragoza, 50009-Zaragoza, Spain,1
and Instituto de Biotecnología, Centro de
Investigaciones en Ciencias Veterinarias (CICV), Instituto Nacional de
Tecnología Agropecuaria (INTA), 1708-Moron,
Argentina2
Received 23 May 2000/Returned for modification 21 August
2000/Accepted 24 November 2000
The Mycobacterium bovis P55 gene, located downstream
from the gene that encodes the immunogenic lipoprotein P27, has been characterized. The gene was identical to the open reading frame of the
Rv1410c gene in the genome of Mycobacterium tuberculosis H37Rv, annotated as a probable drug efflux protein. Genes similar to
P55 were present in all species of the M. tuberculosis complex and other mycobacteria such as
Mycobacterium leprae and Mycobacterium avium.
By Western blotting, P55 was located in the membrane fraction of
M. bovis. When transformed into Mycobacterium
smegmatis after cloning, P55 conferred aminoglycoside and
tetracycline resistance. The levels of resistance to streptomycin and
tetracycline conferred by P55 were decreased in the presence of the
protonophore carbonyl cyanide m-chlorophenylhydrazone and
the pump inhibitors verapamil and reserpine. M. smegmatis
cells expressing the plasmid-encoded P55 accumulated less tetracycline
than the control cells. We conclude that P55 is a membrane protein
implicated in aminoglycoside and tetracycline efflux in mycobacteria.
*
Corresponding author. Mailing address: Departamento de
Microbiología, Medicina Preventiva y Salud Pública,
Facultad de Medicina, Universidad de Zaragoza, C/Domingo Miral s/n,
50009-Zaragoza, Spain. Phone: 34-976-762420. Fax: 34-976-761664. E-mail: ainsa{at}posta.unizar.es.
Antimicrobial Agents and Chemotherapy, March 2001, p. 800-804, Vol. 45, No. 3
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.3.800-804.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ramon-Garcia, S., Martin, C., Thompson, C. J., Ainsa, J. A.
(2009). Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth. Antimicrob. Agents Chemother.
53: 3675-3682
[Abstract]
[Full Text]
-
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., Victor, T. C.
(2009). A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance. Antimicrob. Agents Chemother.
53: 3181-3189
[Full Text]
-
Spies, F. S., Almeida da Silva, P. E., Ribeiro, M. O., Rossetti, M. L., Zaha, A.
(2008). Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism. Antimicrob. Agents Chemother.
52: 2947-2949
[Abstract]
[Full Text]
-
Rodrigues, L., Wagner, D., Viveiros, M., Sampaio, D., Couto, I., Vavra, M., Kern, W. V., Amaral, L.
(2008). Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother
61: 1076-1082
[Abstract]
[Full Text]
-
Farrow, M. F., Rubin, E. J.
(2008). Function of a Mycobacterial Major Facilitator Superfamily Pump Requires a Membrane-Associated Lipoprotein. J. Bacteriol.
190: 1783-1791
[Abstract]
[Full Text]
-
Warner, D. F., Mizrahi, V.
(2006). Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy. Clin. Microbiol. Rev.
19: 558-570
[Abstract]
[Full Text]
-
Piddock, L. J. V.
(2006). Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clin. Microbiol. Rev.
19: 382-402
[Abstract]
[Full Text]
-
Ren, H., Liu, J.
(2006). AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs. Antimicrob. Agents Chemother.
50: 250-255
[Abstract]
[Full Text]
-
Poole, K.
(2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother
56: 20-51
[Abstract]
[Full Text]
-
Carroll, P., Muttucumaru, D. G. N., Parish, T.
(2005). Use of a Tetracycline-Inducible System for Conditional Expression in Mycobacterium tuberculosis and Mycobacterium smegmatis. Appl. Environ. Microbiol.
71: 3077-3084
[Abstract]
[Full Text]
-
Ehrt, S., Guo, X. V., Hickey, C. M., Ryou, M., Monteleone, M., Riley, L. W., Schnappinger, D.
(2005). Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res
33: e21-e21
[Abstract]
[Full Text]
-
Pasca, M. R., Guglierame, P., Arcesi, F., Bellinzoni, M., De Rossi, E., Riccardi, G.
(2004). Rv2686c-Rv2687c-Rv2688c, an ABC Fluoroquinolone Efflux Pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother.
48: 3175-3178
[Abstract]
[Full Text]
-
Li, X.-Z., Zhang, L., Nikaido, H.
(2004). Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother.
48: 2415-2423
[Abstract]
[Full Text]
-
Viveiros, M., Portugal, I., Bettencourt, R., Victor, T. C., Jordaan, A. M., Leandro, C., Ordway, D., Amaral, L.
(2002). Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother.
46: 2804-2810
[Abstract]
[Full Text]